Evaxion A (EVAX) Total Current Liabilities (2019 - 2025)
Evaxion A (EVAX) posted Total Current Liabilities of $4.3 million for Q4 2025, down 20.01% on a QoQ basis from $5.3 million in Q2 2025, and down 2.54% year-over-year from $4.4 million in Q4 2024.
Evaxion A (EVAX) Total Current Liabilities (2019 - 2025) Analysis & Trends
Evaxion A's Total Current Liabilities history runs 7 years deep, the most recent figure standing at $4.3 million for Q4 2025.
- Quarterly Total Current Liabilities fell 2.54% year-over-year to $4.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.3 million (down 2.54% YoY) and the FY2025 annual result came in at $4.3 million, down 2.54% from the prior year.
- Total Current Liabilities was $4.3 million for Q4 2025 at Evaxion A, down from $5.3 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $7.1 million in Q4 2023 and bottomed at $3.8 million in Q4 2022.
- A 5-year average of $4.7 million and a median of $4.4 million in 2024 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2023 — Total Current Liabilities jumped 88.3% — and 2024, when it tumbled 38.34%.
- Evaxion A's Total Current Liabilities stood at $4.3 million in 2021, then decreased by 12.98% to $3.8 million in 2022, then soared by 88.3% to $7.1 million in 2023, then tumbled by 38.34% to $4.4 million in 2024, then slipped by 2.54% to $4.3 million in 2025.
- Business Quant data shows EVAX's Total Current Liabilities at $4.3 million in Q4 2025, $5.3 million in Q2 2025, and $4.4 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 56.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 66.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.81 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 6.38 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 3.88 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.11 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 289.60 Mn |
| 10 | Evaxion A | 25.44 Mn | 25.44 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.26 Mn |
| Jun 30, 2025 | 5.32 Mn |
| Dec 31, 2024 | 4.37 Mn |
| Jun 30, 2024 | 3.82 Mn |
| Dec 31, 2023 | 7.08 Mn |
| Jun 30, 2023 | 4.05 Mn |
| Dec 31, 2022 | 3.76 Mn |
| Jun 30, 2022 | 4.41 Mn |
| Mar 31, 2022 | 4.69 Mn |
| Dec 31, 2021 | 4.32 Mn |
| Sep 30, 2021 | 3.92 Mn |
| Jun 30, 2021 | 4.80 Mn |
| Mar 31, 2021 | 6.02 Mn |
| Dec 31, 2020 | 4.93 Mn |
| Dec 31, 2019 | 1.72 Mn |